United States · FDA National Drug Code directory

Olmesartan medoxomil, amlodipine and hydrochlorothiazide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 31722-893_47b1c419-e608-66b1-e063-6394a90ae253
Product NDC: 31722-893
Form: TABLET, FILM COATED
Composition / generic term: Olmesartan medoxomil, amlodipine and hydrochlorothiazide
Labeler: Camber Pharmaceuticals, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20251006
Source listing expiry: 20271231

Source-listed ingredients

OLMESARTAN MEDOXOMIL — 40 mg/1
AMLODIPINE BESYLATE — 5 mg/1
HYDROCHLOROTHIAZIDE — 12.5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 TABLET, FILM COATED in 1 BOTTLE (31722-893-30) · 31722-893-30
10 BLISTER PACK in 1 CARTON (31722-893-32) / 8 TABLET, FILM COATED in 1 BLISTER PACK (31722-893-31) · 31722-893-32
90 TABLET, FILM COATED in 1 BOTTLE (31722-893-90) · 31722-893-90

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →